Companies Dominating the Negative-pressure Wound Therapy (NPWT) Landscape
- Smith & Nephew, PLC.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Acelity L.P., Inc.
- Cardinal Health
- DeRoyal Industries, Inc.
- Genadyne Biotechnologies, Inc.
- Medela, LLC.
- ConvaTec, Inc.
- ATMOS MedizinTechnik, GmbH & Co. KG
- Talley Group Ltd
- PAUL HARTMANN
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of negative-pressure wound therapy is estimated at USD 2.88 billion.
Negative-pressure Wound Therapy (NPWT) Market size was valued at USD 2.73 billion in 2024 and is likely to cross USD 6.19 billion by 2037, registering more than 6.5% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to hold largest revenue share by 2037, backed by rise in occurrence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers with the increase in geriatric population, increasing healthcare expenditure, and expanding research and development (R&D) activities in the region.
The major players in the market are Smith & Nephew, PLC, Acelity L.P., Inc., Cardinal Health, DeRoyal Industries Inc., Genadyne Biotechnologies, Inc., Medela, LLC., ConvaTec, Inc., ATMOS MedizinTechnik, GmbH & Co. KG, and others.
